• Department of Cardiothoracic Surgery, Anqing Hospital Affiliated to Anhui Medical University, Anqing, 246000, Anhui, P.R.China;
WANG Huan, Email: 84703677@qq.com
Export PDF Favorites Scan Get Citation

Objective To evaluate the efficacy of thoracoscopic complex segmentectomy for stageⅠnon-small cell lung cancer (NSCLC).Methods We retrospectively reviewed the perioperative clinical data of patients with stageⅠNSCLC who underwent thoracoscopic complex segmentectomy (n=58) or simple segmentectomy (n=33) between January 2017 and March 2020 in our hospital. There were 36 males and 55 females with a median age of 57 years (range: 50-66 years). The clinical data of the two groups were compared.Results There were no significant differences between the two groups in characteristics including age, sex, weight, comorbidities, preoperative pulmonary function, dominant composition of tumor, tumor histology and size, overall complications, estimated blood loss, prolonged air leakage, length of hospital stay, length of drainage, surgical margin distance or number of dissected lymph nodes. Only the operation time and number of staples for making intersegmental plane were significantly different between the two groups (P<0.05). There was no perioperative death in both groups.Conclusion Thoracoscopic complex segmentectomy is a feasible and safe technique for stageⅠNSCLC.

Citation: WANG Huan, LIU Jian, CHEN Jian, ZHAN Bicheng. Perioperative outcomes of thoracoscopic complex segmentectomy for stage non-small cell lung cancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(5): 555-559. doi: 10.7507/1007-4848.202005046 Copy

Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved

  • Previous Article

    Influencing factors for prognosis of primary tracheal malignancy and establishment of nomogram model for predicting its overall survival based upon SEER database
  • Next Article

    Effect of glucocorticoid use before radical resection of esophageal cancer on postoperative inflammation indexes and lung inflammation